These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10223737)

  • 21. Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
    Dunbar C; Chang L; Mullen C; Ramsey WJ; Carter C; Kohn D; Parkman R; Lenarsky C; Weinberg K; Wara D; Culver KW; Anderson WF; Leitman S; Fleisher T; Klein H; Shearer G; Clerici M; McGarrity G; Bastian J; Hershfield MS
    Hum Gene Ther; 1999 Feb; 10(3):477-88. PubMed ID: 10048399
    [No Abstract]   [Full Text] [Related]  

  • 22. End-of-the-year potpourri--1993.
    Anderson WF
    Hum Gene Ther; 1993 Dec; 4(6):701-2. PubMed ID: 8186284
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.
    Walsh P; Gonzalez R; Dow S; Elmslie R; Potter T; Glode LM; Baron AE; Balmer C; Easterday K; Allen J; Rosse P
    Hum Gene Ther; 2000 Jun; 11(9):1355-68. PubMed ID: 10890744
    [No Abstract]   [Full Text] [Related]  

  • 24. End-of-the-year potpourri--1995.
    Anderson WF
    Hum Gene Ther; 1995 Dec; 6(12):1505-6. PubMed ID: 8664374
    [No Abstract]   [Full Text] [Related]  

  • 25. Autologous bone marrow transplant for children with AML in first complete remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.
    Hum Gene Ther; 1991; 2(2):137-59. PubMed ID: 1911934
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo drug-selectable markers in gene therapy.
    Sugimoto Y; Tsuruo T
    Leukemia; 1997 Apr; 11 Suppl 3():552-6. PubMed ID: 9209454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.
    Amado RG; Mitsuyasu RT; Symonds G; Rosenblatt JD; Zack J; Sun LQ; Miller M; Ely J; Gerlach W
    Hum Gene Ther; 1999 Sep; 10(13):2255-70. PubMed ID: 10498256
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
    Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
    Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte gene therapy.
    Culver KW; Anderson WF; Blaese RM
    Hum Gene Ther; 1991; 2(2):107-9. PubMed ID: 1911929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a clinical protocol for hepatic gene transfer: lessons learned in preclinical studies.
    Ledley FD; Adams RM; Soriano HE; Darlington G; Finegold M; Lanford R; Carey D; Lewis D; Baley PA; Rothenberg S
    Pediatr Res; 1993 Apr; 33(4 Pt 1):313-20. PubMed ID: 8386832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD).
    Batshaw ML; Wilson JM; Raper S; Yudkoff M; Robinson MB
    Hum Gene Ther; 1999 Sep; 10(14):2419-37. PubMed ID: 10515461
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.
    Stedman H; Wilson JM; Finke R; Kleckner AL; Mendell J
    Hum Gene Ther; 2000 Mar; 11(5):777-90. PubMed ID: 10757357
    [No Abstract]   [Full Text] [Related]  

  • 33. Transduction of CD34+ cells from the bone marrow of HIV-1-infected children: comparative marking by an RRE decoy gene and a neutral gene.
    Hum Gene Ther; 2000 Jul; 11(11):1577-90. PubMed ID: 10945771
    [No Abstract]   [Full Text] [Related]  

  • 34. Suicide gene therapy for urogenital cancer: current outcome and prospects.
    Nasu Y; Kusaka N; Saika T; Tsushima T; Kumon H
    Mol Urol; 2000; 4(2):67-71. PubMed ID: 12006245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
    [No Abstract]   [Full Text] [Related]  

  • 36. NIH Recombinant DNA Advisory Committee data management report. March 12, 1999.
    Hum Gene Ther; 1999 Jun; 10(9):1577-89. PubMed ID: 10395382
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
    Janson C; McPhee S; Bilaniuk L; Haselgrove J; Testaiuti M; Freese A; Wang DJ; Shera D; Hurh P; Rupin J; Saslow E; Goldfarb O; Goldberg M; Larijani G; Sharrar W; Liouterman L; Camp A; Kolodny E; Samulski J; Leone P
    Hum Gene Ther; 2002 Jul; 13(11):1391-412. PubMed ID: 12162821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical considerations in pulmonary genetic testing and gene therapy.
    Kimyai-Asadi A; Terry PB
    Am J Respir Crit Care Med; 1997 Jan; 155(1):3-8. PubMed ID: 9001280
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
    Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
    Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards.
    Burger IM; Wilfond BS
    Hum Gene Ther; 2000 May; 11(7):1057-63. PubMed ID: 10811234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.